These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4316120)

  • 41. [Complications of polychemotherapy for renal tuberculosis].
    Kul'chavenia EV; Kuznetsov PV
    Probl Tuberk; 1998; (1):28-30. PubMed ID: 9553430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure.
    Kocabay G; Erelel M; Tutkun IT; Ecder T
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1418-9. PubMed ID: 17171829
    [No Abstract]   [Full Text] [Related]  

  • 43. [Statement on tuberculosis treatment].
    Rasmussen KN
    Ugeskr Laeger; 1973 Aug; 135(34):1829-30. PubMed ID: 4781310
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
    Kaminskaia GO; Karachunskiĭ MA; Kolosovskaia VP
    Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
    [No Abstract]   [Full Text] [Related]  

  • 45. [Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968].
    Erhard G
    Med Klin; 1969; 64(26):1215-7. PubMed ID: 4979959
    [No Abstract]   [Full Text] [Related]  

  • 46. Adverse reactions to drugs used in the treatment of tuberculosis.
    Nariman S
    Adverse Drug React Acute Poisoning Rev; 1988; 7(4):207-27. PubMed ID: 3071113
    [No Abstract]   [Full Text] [Related]  

  • 47. [Characteristics of drug-induced hepatitis in patients with tuberculosis].
    Vil'derman AM
    Probl Tuberk; 1972; 50(5):59-63. PubMed ID: 4112966
    [No Abstract]   [Full Text] [Related]  

  • 48. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of tuberculosis in childhood].
    Dürr DK; Wissler H
    Ther Umsch; 1972 Dec; 29(12):743-6. PubMed ID: 4639116
    [No Abstract]   [Full Text] [Related]  

  • 50. A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in central massachusetts.
    Young H; Wessolossky M; Ellis J; Kaminski M; Daly JS
    Clin Infect Dis; 2009 Aug; 49(3):424-7. PubMed ID: 19548835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Present status and treatment of urogenital tuberculosis].
    Osterhage HR; Haubensak K
    Urologe A; 1975 Jan; 14(1):1-5. PubMed ID: 803728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of tuberculous meningitis in adults: current trends and problems].
    Gallofre López M; Latorre Murillo P; Massons Cirera J; Sumalla Suñe J
    Rev Clin Esp; 1982 Sep; 166(6):317-9. PubMed ID: 6758078
    [No Abstract]   [Full Text] [Related]  

  • 54. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary and acquired drug resistance in childhood tuberculosis.
    Khalilzadeh S; Boloorsaz MR; Safavi A; Farnia P; Velayati AA
    East Mediterr Health J; 2006 Nov; 12(6):909-14. PubMed ID: 17333839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of chromosomal aberrations in patients under combined tuberculostatic chemotherapy.
    Roman IC; Vainer E; Socosan I; Drăghicescu T
    Hum Genet; 1983; 63(2):191-2. PubMed ID: 6840764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Reflex algodystrophic syndrome after tuberculostatic agents].
    Navrátil J
    Fysiatr Revmatol Vestn; 1969 Apr; 47(2):73-81. PubMed ID: 4976438
    [No Abstract]   [Full Text] [Related]  

  • 60. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis.
    Ena J; Valls V
    Clin Infect Dis; 2005 Mar; 40(5):670-6. PubMed ID: 15714411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.